In vitro study | Galeterone is an effective pre-blocking [. In PC3 cells, Galeterone also inhibits [. Galeterone potently inhibited the proliferation of androgen-independent cell lines PC - 3 and DU-145 in a dose-dependent manner with GI50 of 7.82 μm and 7.55 μm, respectively. The endoplasmic reticulum stress response induced by Galeterone results in down-regulation of cyclin D1 protein expression and cyclin E2 mRNA. Galeterone effectively inhibited HP-LNCaP and C4-2B proliferation with IC 50 of 2.9 μm and 9.7 μm, respectively. 1 μm Galeteron effectively inhibited androgen receptor activation, with inhibition rates of 50% in LNCaP and 70% in HP-LNCaP. In LNCaP cells and HP-LNCaP cells, Galeterone reduced androgen receptor activation with IC 50 of 1 μm and 411 nM, respectively, and down-regulated androgen receptor protein expression by 50% after 24-h treatment. Galeterone reduces AR protein and mRNA expression, antagonizes androgen-induced AR-dependent promoter activation, and significantly reduces phosphorylated -4EBP1 levels |